New imaging technology: Measurement of myocardial perfusion by contrast echocardiography

Coronary Artery Disease

Volumn 11, Issue 3, 2000, Pages 221-226

  Rubin, David N ^a   Thomas, James D ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Department of Cardiology ^*  (United States)

Author keywords

Coronary artery disease; Image processing; Indicator dilution; Myocardial perfusion; Ultrasound

Indexed keywords

CONTRAST MEDIUM;

CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY DISEASE; HEART MUSCLE PERFUSION; HUMAN; IMAGING; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; REVIEW;

NASA DISCIPLINE CARDIOPULMONARY; NASA PROGRAM BIOMEDICAL RESEARCH AND COUNTERMEASURES; NON-NASA CENTER;

CONTRAST MEDIA; CORONARY CIRCULATION; ECHOCARDIOGRAPHY; HUMANS; INDICATOR DILUTION TECHNIQUES; MYOCARDIAL ISCHEMIA;

EID: 0034076345     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200005000-00004     Document Type: Review

References (36)

1. 1 Zierler KR. A simplified explanation of the theory of indicator-dilution for measurement of fluid flow and volume and other distributive phenomena. Bull Johns Hopkins Hosp 1958; 103:199-223.
2. 2 Mullani NA, Goldstein RA, Gould KL, Marini SK, Fisher DJ, O'Brien HA, Lobeng MD. Myocardial perfusion with rubidium-82. I. Measurement of extraction fraction and flow with external detectors. J Nucl Med 1983; 24:898-906.
3. 3 Meier P, Zierler KL. On the theory of indicator-dilution method for measurement of blood flow and volume. J Appl Physiol 1954; 6:731-740.
4. 4 Schwarz KQ, Chen X, Steinmetz S, Phillips D. Harmonic imaging with Levovist. J Am Soc Echocardiogr 1997; 10:1-10.
5. 5 Mor-Avi V, David D, Akselrod S, Bitton Y, Choshniak I. Myocardial regional blood flow: quantitative measurement by computer analysis of contrast enhanced echocardiographic images. Ultrasound Med Biol 1993; 19:619-633.
6. 6 Powsner SM, Keller MW, Saniie J, Feinstein SB. Quantitation of echo-contrast effects. Am J Physiologic Imaging 1986; 1:124-128.
7. 7 Schwarz KQ, Bezante GP, Chen X, Mottley JG, Schlief R. Volumetric arterial flow quantification using echo contrast. An in vitro comparison of three ultrasonic intensity methods: radio frequency, video and Doppler. Ultrasound Med Biol 1993; 19:447-460.
8. 8 Mor-Avi V, Akselrod S, David D, Keselbrener L, Bitton Y. Myocardial transit time of the echocardiographic contrast media. Ultrasound Med Biol 1993; 19:635-648.
9. 9 Jayaweera AR, Edwards N, Glasheen WP, Villanueva FS, Abbott RD, Kaul S. In vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography. Comparison with radiolabeled red blood cells. Circ Res 1994; 74:1157-1165. Demonstrates that the rheology of albumin microspheres is indistinguishable from red cells, supporting their use in the assessment of myocardial perfusion.
10. 10 Ota T, Hillman ND, Craig D, Kisslo J, Smith PK. Contrast echocardiography: influence of ultrasonic machine settings, mixing conditions, and pressurization on pixel intensity and microsphere size of Albunex solutions in vitro. J Am Soc Echocardiogr 1997; 10:31-40.
11. 11 Porter TR, Xie F, Kricsfeld A, Deligonul U, Kilzer K. Reduction in left ventricular cavitary attenuation and improvement in posterior myocardial contrast with higher molecular weight intravenous perfluorocarbon-exposed sonicated dextrose albumin microbubbles. J Am Soc Echocardiogr 1996; 9:437-441. Demonstration that bubbles with encapsulated gas of higher molecular weight and lower diffusivity than air are more stable with superior imaging characteristics.
12. 12 Tiukinhoy S, Bhoopalam S, Winkelmann JW, Ammar K, Mangulabran L, Reddy G, et al. Loss of contrast intensity during systole in the left ventricular cavity with the use of the contrast agent Albunex. An analysis of its correlation with pressure and velocity. Invest Radiol 1996; 31:415-422.
13. 13 de Jong N, Hoff L, Skotland T, Bom N. Absorption and scatter of encapsulated gas filled microspheres: theoretical considerations and some measurements. Ultrasonics 1992; 30:95-103.
14. 14 Morse PM, Ingard KU. Theoretical acoustics. New York: McGraw-Hill; 1968. pp. 418-427.
15. 15 Morse PM, Ingard KU. Theoretical acoustics. New York: McGraw-Hill; 1968. pp. 436-441.
16. 16 Vandenberg BF, Melton HE. Acoustic lability of albumin microspheres. J Am Soc Echocardiogr 1994; 7:582-589.
17. 17 Wei K, Skyba DM, Firschke C, Jayaweera AR, Lindner JR, Kaul S. Interactions between microbubbles and ultrasound: in vitro and in vivo observations. J Am Coll Cardiol 1997; 29:1081-1088.
18. 18 de Jong N, Cornet R, Lancee CT. Higher harmonics of vibrating gas-filled microspheres. Part one: simulations. Ultrasonics 1994; 32:447-453. Mathematical analysis and computer simulation demonstrating that when microbubbles are insonified below their resonant frequency, they emit energy at multiples of the insonifying energy.
19. 19 Tucker DG, Welsby VG. Ultrasonic monitoring of decompression. Lancet 1968, i:1253.
20. 20 Miller DL. Ultrasonic detection of resonant cavitation bubbles in a flow tube by their second-harmonic emissions. Ultrasonics 1981; 19:217-224.
21. 21 de Jong N, Ten Cate FJ, Lancee CT, Roelandt JR, Bom N. Principles and recent developments in ultrasound contrast agents. Ultrasonics 1991; 29:324-330.
22. 22 Lauterborn W. Numerical investigation of nonlinear oscillations of gas bubbles in liquids. J Acoust Soc Am 1976; 59:283-293.
23. 23 Burns PN. Harmonic imaging with ultrasound contrast agents. Clin Radiol 1996; 51:50-55.
24. 24 de Jong N, Cornet R, Lancee CT. Higher harmonics of vibrating gas-filled microspheres. Part two: measurements. Ultrasonics 1994; 32:455-459. In vitro measurements confirming than when microbubbles are insonified below their resonant frequency, they emit energy at multiples of the insonifying frequency.
25. 25 Porter TR, Xie F. Transient myocardial contrast following initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles: demonstration and potential mechanisms. Circulation 1995; 92:2391-2395. Earty report of bubble destruction by ultrasound and perfusion assessment by triggered imaging.
26. 26 Kaul S, Senior R, Dittrich H, Rava U, Khattar R, Lahiri A. Detection of coronary artery disease with myocardial contrast echocardiography: comparison with 99mTc-sestamibi single-photon emission computed tomography. Circulation 1997; 96:785-792. Validation of ultrasonic imaging of perfluorocarbon filled microspheres in patients with chronic coronary artery disease.
27. 27 Lindner JR, Dent JM, Moos SP, Jayaweera AR, Kaul S. Enhancement of left ventricular cavity opacification by harmonic imaging after venous injection of Albunex. Am J Cardiol 1997; 79:1657-1662.
28. 28 Porter TR, Li S, Kilzer K, Deligonul U. Effect of significant two-vessel versus one-vessel coronary artery stenosis on myocardial contrast defects observed with intermittent harmonic imaging after intravenous contrast injection during dobutamine stress echocardiography. J Am Coll Cardiol 1997; 30:1399-1406.
29. 29 Porter TR, Xie F, Shouping L, D'sa A, Rafter P. Increased ultrasound contrast and decreased microbubble destruction rates with triggered ultrasound imaging. J Am Soc Echocardiogr 1996; 9:599-605. Validation of triggered imaging to enhance the strength of myocardial contrast.
30. 30 Porter TR, Xie F, Kilzer K, Deligonul U. Detection of myocardial perfusion abnormalities during dobutamine and adenosine stress echocardiography with transient myocardial contrast imaging after minute quantities of intravenous perfluorocarbon-exposed sonicated dextrose albumin. J Am Soc Echocardiogr 1996; 9:779-786.
31. 31 Porter T, Li S, Deligonul U, Oster R. Detection of no-reflow zones using intravenous ultrasound contrast and intermittent harmonic imaging in patients with acute myocardial infarction and angiographically successful recanalization [abstract]. J Am Soc Echocardiogr 1997; 10:413.
32. 32 Colon PJ, Richards DR, Moreno CA, Murgo JP, Cheirif J. Benefits of reducing the cardiac cycle-triggering frequency of ultrasound imaging to increase myocardial opacification with FSO69 during fundamental and second harmonic imaging. J Am Soc Echocardiogr 1997; 10:602-607.
33. 33 Firschke C, Lindner JR, Wei K, Goodman NC, Skyba DM, Kaul S. Myocardial perfusion imaging in the setting of coronary artery stenosis and acute myocardial infarction using venous injection of a second-generation echocardiographic contrast agent. Circulation 1997; 96:959-967.
34. 34 Firschke C, Lindner JR, Goodman NC, Skyba DM, Wei K, Kaul S. Myocardial contrast echocardiography in acute myocardial infarction using aortic root injections of microbubbles in conjunction with harmonic imaging: potential application in the cardiac catheterization laboratory. J Am Coll Cardiol 1997; 29:207-216.
35. 35 Porter TR, Li S, Kricsfeld D, Armbruster RW. Detection of myocardial perfusion in multiple echocardiographic windows with one intravenous injection of microbubbles using transient response second harmonic imaging. J Am Coll Cardiol 1997; 29:791-799.
36. 36 Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998; 97:473-483. In vitro and animal validation of the concept of bubble destruction and fill-in as an approach to the quantification of myocardial blood flow. After destroying microbubbles within a slab of myocardium, intensity increases exponentially (proportional to blood velocity) to an asymptotic value (proportional to blood volume).